4.6 Letter

Secukinumab improves mild-to-moderate psoriasis: A randomized, placebo-controlled exploratory clinical trial

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 88, Issue 2, Pages 428-430

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2022.04.060

Keywords

dendritic cells; gene expression; IL-17; mild-to-moderate disease; psoriasis; secukinumab; type 17 T cells; T cells

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available